As of January 22, 2025, Adagene (ADAG) has a market cap of $79.687 million USD. According to our data, Adagene is ranked No.7855 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $79.69 M |
-9.55%
|
Dec 31, 2024 | $88.10 M |
3.06%
|
Dec 29, 2023 | $85.49 M |
45.74%
|
Dec 30, 2022 | $58.66 M |
-83.58%
|
Dec 31, 2021 | $0.36 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.77 B |
0.000 M
|
USA
|
Merck
MRK
|
$242.01 B |
0.005 M
|
USA
|
Pfizer
PFE
|
$147.43 B |
0.004 M
|
USA
|
Eli Lilly
LLY
|
$677.80 B |
-0.006 M
|
USA
|
Novartis
NVS
|
$196.25 B |
0.003 M
|
Switzerland
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Johnson & Johnson
JNJ
|
$349.71 B |
-0.006 M
|
USA
|
AbbVie
ABBV
|
$298.91 B |
0.013 M
|
USA
|
GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
Market Cap | = | ADAG Stock Price | * | ADAG Shares Outstanding |
= | $1.80 | * | 44.27 M | |
= | $79.69 M |